Gyermekkori daganatok: vizsgálatok itt: Spanyolország
151 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours
- Where
- Barakaldo, Barcelona, Esplugues De Llobregat, Madrid, Sevilla, Valencia
- Életkor
- Up to 64 év
- People
- 48
- Run by
- Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
See details and how to join2023-504246-64-02 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander, Santiago de Compostela, Valencia
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleLong-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.
- Where
- Barcelona, Madrid, Valencia
- People
- 21
- Run by
- Autolus Limited
See details and how to join2024-511684-28-00 - No phaseTaking peopleTelematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
- Where
- Madrid
- Életkor
- 8 év to 18 év
- People
- 40
- Run by
- Hospital Universitario La Paz
See details and how to joinNCT07479927 - 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Málaga, Murcia, Palma, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - 1. fázisTaking peopleSafety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
- Where
- Barcelona, Esplugues de Llobregat
- Életkor
- 2 év and over
- People
- 20
- Run by
- OneChain Immunotherapeutics
See details and how to joinNCT05679895 · EU 2024-514591-40-00 - No phaseTaking peopleRole of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases
- Where
- Pamplona
- People
- 60
- Run by
- Clinica Universidad de Navarra, Universidad de Navarra
See details and how to joinNCT07447440 - 2/3. fázisNot yet taking people in SpanyolországA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Esplugues de Llobregat, Madrid, Valencia
- Életkor
- Up to 25 év
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Las Palmas, Madrid
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - No phaseNot yet taking people in SpanyolországDigital Solutions for bEtter cAre
- Where
- Barcelona
- Életkor
- 12 év and over
- People
- 200 worldwide
- Run by
- European Institute of Oncology
See details and how to joinNCT07416513 - No phaseTaking peopleSpanish Validation of a Psychosocial Needs Assessment for Adolescents and Young Adults With Cancer (AYA-POST)
- Where
- Barcelona
- Életkor
- 15 év to 25 év
- People
- 100
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07240935 - 1/2. fázisNot yet taking people in SpanyolországA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Barakaldo, Barcelona, Madrid, Sevilla, Valencia
- Életkor
- 1 év to 64 év
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00 - No phaseTaking peopleInternational Leukemia Target Board
- Where
- Barcelona
- Életkor
- 0 év to 25 év
- People
- 600 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05270096 - No phaseCsak meghívásosAnalysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center
- Where
- Huelva
- People
- 300
- Run by
- María Teresa Moreno Asencio
See details and how to joinNCT05404503 - 1/2. fázisTaking peopleBrigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 1 év to 25 év
- People
- 65 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00 - No phaseTaking peopleModerate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study
- Where
- Madrid
- People
- 10
- Run by
- Universidad Rey Juan Carlos
See details and how to joinNCT07128030 - 1. fázisTaking peopleVyClo ITCC-092
- Where
- Barcelona, Esplugues De Llobregat, Madrid
- Életkor
- Up to 64 év
- People
- 25 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-508050-26-00 - 1. fázisTaking peoplePhase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
- Where
- Madrid
- Életkor
- Up to 30 év
- People
- 10
- Run by
- Instituto de Investigación Hospital Universitario La Paz
See details and how to joinNCT06709469 - 1/2. fázisTaking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - 1/2. fázisTaking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - 1/2. fázisTaking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - No phaseTaking peopleAPACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 16 év and over
- People
- 40 worldwide
- Run by
- University of Manchester
See details and how to joinNCT06868355 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Oviedo, Palma, Santander, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01 - 1. fázisTaking peopleStudy Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
- Where
- Barcelona, Valencia
- Életkor
- 18 hónap to 18 év
- People
- 38 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00 - 3. fázisTaking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Barakaldo, Barcelona, Donostia, El Palmar, Murcia, Madrid, Malaga, Palma, Santiago de Compostela, Sevilla, Valencia
- Életkor
- Up to 21 év
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00